Mexico - Delayed Quote MXN

Cassava Sciences, Inc. (SAVA.MX)

416.00 0.00 (0.00%)
At close: February 12 at 2:22 PM CST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
105,957.00
105,957.00
80,020.00
32,868.00
6,792.00
Operating Income
-105,957.00
-105,957.00
-80,020.00
-32,868.00
-6,792.00
Net Non Operating Interest Income Expense
7,833.00
7,833.00
2,777.00
49.00
112.00
Other Income Expense
907.00
907.00
997.00
434.00
346.00
Pretax Income
-97,217.00
-97,217.00
-76,246.00
-32,385.00
-6,334.00
Net Income Common Stockholders
-97,217.00
-97,217.00
-76,246.00
-32,385.00
-6,334.00
Diluted NI Available to Com Stockholders
-97,217.00
-97,217.00
-76,246.00
-32,385.00
-6,334.00
Basic EPS
-2.32
-2.32
-1.90
-0.82
-0.24
Diluted EPS
-2.32
-2.32
-1.90
-0.82
-0.24
Basic Average Shares
41,932.00
41,932.00
40,202.00
39,405.00
26,105.00
Diluted Average Shares
41,932.00
41,932.00
40,202.00
39,405.00
26,105.00
Total Operating Income as Reported
-105,957.00
-105,957.00
-80,020.00
-32,868.00
-6,446.00
Total Expenses
105,957.00
105,957.00
80,020.00
32,868.00
6,792.00
Net Income from Continuing & Discontinued Operation
-97,217.00
-97,217.00
-76,246.00
-32,385.00
-6,334.00
Normalized Income
-97,217.00
-97,217.00
-76,246.00
-32,385.00
-6,680.00
Interest Income
7,833.00
7,833.00
2,777.00
49.00
112.00
Net Interest Income
7,833.00
7,833.00
2,777.00
49.00
112.00
EBIT
-105,957.00
-105,957.00
-80,020.00
-32,868.00
-6,792.00
EBITDA
-104,427.00
-104,427.00
-78,719.00
-32,334.00
-6,770.00
Reconciled Depreciation
1,530.00
1,530.00
1,301.00
534.00
22.00
Net Income from Continuing Operation Net Minority Interest
-97,217.00
-97,217.00
-76,246.00
-32,385.00
-6,334.00
Total Unusual Items Excluding Goodwill
--
--
--
--
346.00
Total Unusual Items
--
--
--
--
346.00
Normalized EBITDA
-104,427.00
-104,427.00
-78,719.00
-32,334.00
-7,116.00
12/31/2020 - 9/20/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VRPX Virpax Pharmaceuticals, Inc.
3.1000
+8.01%
 
ASLN ASLAN Pharmaceuticals Limited
0.4153
-7.30%
 
ADTX Aditxt, Inc.
2.3900
-5.53%
 
EQ Equillium, Inc.
1.7100
-5.52%
 
NRXP NRx Pharmaceuticals, Inc.
3.5400
+12.74%
 
RAPT RAPT Therapeutics, Inc.
8.10
+3.85%
 
MDGL Madrigal Pharmaceuticals, Inc.
193.33
-0.54%
 
VRTX Vertex Pharmaceuticals Incorporated
397.48
-0.06%
 
IOVA Iovance Biotherapeutics, Inc.
11.64
+0.87%